Pro-oxidative interactions of cobalt with human neutrophils

Inhalation Toxicology

Volumn 16, Issue 9, 2004, Pages 649-655

  Ramafi, Grace J ^a   Theron, Annette J ^b,c   Anderson, Ronald ^b,c  

^a National Centre for Occupational Health   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

5,5 DIMETHYL 1 PYRROLINE 1 OXIDE; ALPHA 1 ANTITRYPSIN; BENZOIC ACID; COBALT; HEAVY METAL; HYDROGEN PEROXIDE; HYDROXYL RADICAL; LUMINOL; MANNITOL; PHORBOL 13 ACETATE 12 MYRISTATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; HUMAN; HUMAN CELL; IN VIVO STUDY; NEUTROPHIL; OXIDATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REACTION ANALYSIS; TISSUE INJURY;

ADENOSINE TRIPHOSPHATE; ADULT; ALPHA 1-ANTITRYPSIN; CELL MEMBRANE; CHEMILUMINESCENT MEASUREMENTS; COBALT; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; HYDROGEN PEROXIDE; INDICATORS AND REAGENTS; LEUKOCYTE ELASTASE; LUMINOL; NADPH OXIDASE; NEUTROPHILS; OXIDANTS; OXIDATION-REDUCTION; OXYGEN CONSUMPTION;

LETHRINIDAE;

EID: 3342892856     PISSN: 08958378     EISSN: None     Source Type: Journal    
DOI: 10.1080/08958370490464661     Document Type: Article

References (32)

1. Adami, G., Smarrelli, D., Martinelli, B., Acquavita, A., and Reisenhofer, E. 2003. Cobalt blood levels after total hip replacement (THR): A new follow-up study in Trieste (Italy). Ann. Chim. 93:1-10.
2. Barnes, P. J. 1989. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J. Allergy Clin. Immunol. 83:1013-1026.
3. Barnes, P. J. 1998. New therapies for chronic obstructive pulmonary disease. Thorax 53:137-147.
4. Beatty, K., Robertie, P., Senior, R. M., and Travis, J. 1982. Determination of oxidized alpha-1-proteinase inhibitor in serum. J. Lab. Clin. Med. 100:186-192.
5. Brock, T., and Stopford, W. 2003. Bioaccessibility of metals in human health risk assessment: Evaluating risk from exposure to cobalt compounds. J. Environ. Monit. 5:71N-76N.
6. Cbristensen, J. M., and Poulsen, O. M. 1994. A 1982-1992 surveillance programme on Danish pottery painters. Biological levels and health effects following exposure to soluble or insoluble cobalt compounds in cobalt blue dyes. Sci. Total. Environ. 150:201-207.
7. Das, S., and Punniyamurthy, T. 2003. Cobalt (II)-catalyzed oxidation of alcohols into carboxylic acids and ketones with hydrogen peroxide. Tetrahedron Lett. 44:6033-6035.
8. Dick, C. A. J., Brown, D. M., Donaldson, K., and Stone, V. 2003. The role of free radicals in the toxic and inflammatory effects of four different ultrafine particle types. Inhal. Toxicol. 15:39-52.
9. Douwes, J., Gibson, P., Pekkanen, J., and Pearce, N. 2002. Noneosinophilic asthma: Importance and possible mechanisms. Thorax 57:643-648.
10. 2+. J. Inorg. Biochem. 88:144-152.
11. El-Hag, A., Lipsky, P. E., Bennett, M., and Clark, R. A. 1987. Immunomodulation by neutrophil myeloperoxidase and hydrogen peroxide: Differential susceptibility of human lymphocyte functions. J. Immunol. 139:1406-2413.
12. Feldman, C., Anderson, R., Kanthakumar, K., Vargas, A., Cole, P. J., and Wilson, R. 1994. Oxidant-mediated ciliary dysfunction in human respiratory epithelium. Free Radical. Biol. Med. 17:1-10.
13. Greene, C., Taggart, C., Lowe, G., Gallagher, P., McElvaney, N., and O'Neill, S. 2003. Local impairment of anti-neutrophil elastase in community acquired pneumonia. J. Infect. Dis. 188:769-776.
14. Hiemstra, P. S. 2002. Novel roles of protease inhibitors in infection and inflammation. Biochem. Soc. Trans. 30:116-120.
15. Holmsen, H. E., Storm, E., and Day, H. J. 1972. Determination of ATP and ADP in blood platelets: A modification of the firefly luciferase assay for plasma. Anal. Biochem. 46:481-502.
16. Lauwerys, R., and Lison, D. 1994. Health risks associated with cobalt exposure - An overview. Sci. Total Environ. 150:1-6.
17. Lehr, H.-A., Frei, B., and Arfors, K. E. 1993. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to vascular endothelium. Proc. Natl. Acad. Sci. USA 91:7688-7692.
18. Lieberman, J. 2000. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency - A new hypothesis with supporting data. Chest 118:1480-1485.
19. Lim, Y. P., Bendelja, K., Opal, S. M., Siryapom, E., Hixson, D. C., and Palardy, J. E. 2003. Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. J. Infect. Dis. 188:919-926.
20. Linna, A., Oksa, P., Palmroos, P., Roto, P., Laippala, P., and Uitti, J. 2003. Respiratory health of cobalt production workers. Am. J. Ind. Med. 44:124-132.
21. 1-antitrypsin. J. Biol. Chem. 275:7693-7700.
22. Nemery, B., Lewis, C. P. L., and Demedts, M. 1994. Cobalt and possible oxidant-mediated injury. Sci. Total Environ. 150:57-64.
23. Nuorti, J. P., Butler, J. C., Farley, M. M., Harrison, L. H., McGreer, A., Kolczak, M. S., and Breiman, R. F. 2000. Cigarette smoking and invasive pneumococcal disease. N. Engl. J. Med. 342:681-689.
24. Richards, G. A., Theron, A. J., Van der Merwe, C. A., and Anderson, R. 1989. Spirometric abnormalities in young smokers correlate with increased chemiluminescence responses of activated blood phagocytes. Am. Rev. Respir. Dis. 139:181-187.
25. Shapiro, L., Pott, G. B., and Ralston, A. H. 2001. Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1. FASEB J. 15:115-122.
26. Stockley, R. A., Shaw, J., Afford, S. C., Morrison, H. M., and Burnett, D. 1990. Effects of alpha-1-proteinase inhibitor on neutrophil chemotaxis. Am. J. Respir. Cell Mol. Biol. 2:163-170.
27. Stockley, R. A., Bayley, D. L., Unsal, I., and Dowson, L. J. 2002. The effect of augmentation therapy on bronchial inflammation in alpha-1-antitrypsin deficiency. Am. J. Respir. Crit. Care Med. 165:1494-1498.
28. Swennen, B., Buchet, J.-P., Stanescu, D., Lison, D., and Lauwerys, R. 1993. Epidemiological survey of workers exposed to cobalt oxides, cobalt salts, and cobalt metal. Br. J. Ind. Med. 50:835-842.
29. Weiss, S. J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320:365-376.
30. Weitzman, S. A., and Gordon, L. I. 1990. Inflammation and cancer: Role of phagocyte-generated oxidants in carcinogenesis. Blood 76:655-663.
31. 4 and interleukin 8. Thorax 57:709-714.
32. Wright, J. L., Farmer, S. G., and Churg, A. 2003. A neutrophil elastase inhibitor reduces cigarette smoke-induced remodelling of lung vessels. Eur. Respir. J. 22:77-81.